Rosetta Genomics Posts Q4 Revenues Following Product Launches

Rosetta reported revenues of $119,000 for the fourth quarter compared to no revenues in Q3 2009 and the comparable period of Q4 2008. The firm's first three tests were launched late in the year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories